Chronic opioid use is associated with obstructive and spastic disorders in the esophagus.

Abstract

BACKGROUND AND AIMS\nChronic opioid effects on the esophagus are poorly understood. We investigated whether opioids were associated with increased prevalence of esophageal motility disorders.\n\n\nMETHODS\nA retrospective study of all patients undergoing high-resolution manometry (HREM) at the Yale Gastrointestinal Motility Lab between January 2014 and August 2019. Data were extracted from the electronic medical record after studies were reviewed by two motility specialists using the Chicago Classification v.3.0. We compared the manometric results of patients who use opioids to those who do not and adjusted for type and dose of opioids using a 24\xa0h Morphine Milligram Equivalents (MME) scale to compare patients taking low or high amounts of opioids.\n\n\nRESULTS\nFour manometric abnormalities were significantly different between the opioid and non-opioid users. Achalasia type III, esophagogastric junction outflow obstruction (EGJOO), and distal esophageal spasm (DES) (p\xa0<\xa00.005, p\xa0<\xa00.01, and p\xa0<\xa00.005, respectively) were common among opioid users, whereas ineffective esophageal motility (IEM) was more common among non-opioid users (p\xa0<\xa00.01). The incidence of EGJOO was significantly higher in opioid users compared to non-opioid users (p\xa0<\xa00.001). Lastly, IRP, DCI, and distal latency were significantly different between the two groups. Patients in the high MME group had significantly greater IRP, DCI, and lower distal latency than non-opioids (p\xa0<\xa00.001). Also, achalasia type III and DES were more common in the high but not the low MME group.\n\n\nCONCLUSIONS\nOpioid use is associated with multiple abnormalities on esophageal motility and these effects may be dose-dependent.